We can’t show the full text here under this license.
Lower levels of MLH1 and PMS2 are linked to temozolomide resistance and glioblastoma returning
Updated
Abstract
A reduction in expression of MLH1 and PMS2 was observed in TMZ-resistant glioblastoma cells.
- DNA repair deficiency is related to temozolomide (TMZ) resistance in glioblastoma.
- Three TMZ-resistant human glioblastoma cell lines were isolated for analysis.
- Reduced levels of MLH1 were associated with decreased PMS2 protein levels in resistant cells.
- Knockdown of MLH1 or PMS2 resulted in increased resistance to TMZ.
- Recurrent glioblastoma tumors exhibited lower expression of MLH1 and PMS2 compared to primary tumors.
Simplified